ICAM1 and neoplasm: However, low doses of IFN-γ produced at the tumor site by host-infiltrating cells or during immunotherapy can enhance tumor cell survival, induce risk of metastasis and expression of EMT transcription factors [174,175] via activation of ICAM1-PI3K-Akt-Notch1 signaling in cancer cells [414].